These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27164846)

  • 1. Contact heat sensitivity and reports of unpleasantness in communicative people with mild to moderate cognitive impairment in Alzheimer's disease: a cross-sectional study.
    Monroe TB; Gibson SJ; Bruehl SP; Gore JC; Dietrich MS; Newhouse P; Atalla S; Cowan RL
    BMC Med; 2016 May; 14():74. PubMed ID: 27164846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex Differences in the Psychophysical Response to Contact Heat in Moderate Cognitive Impairment Alzheimer's Disease: A Cross-Sectional Brief Report.
    Cowan RL; Beach PA; Atalla SW; Dietrich MS; Bruehl SP; Deng J; Wang J; Newhouse PA; Gore JC; Monroe TB
    J Alzheimers Dis; 2017; 60(4):1633-1640. PubMed ID: 28968238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Alzheimer's Disease on the Resting State Functional Connectivity of Brain Regions Modulating Pain: A Cross Sectional Study.
    Monroe TB; Beach PA; Bruehl SP; Dietrich MS; Rogers BP; Gore JC; Atalla SW; Cowan RL
    J Alzheimers Dis; 2017; 57(1):71-83. PubMed ID: 28222526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex Differences in Associations of Cognitive Function with Perceptions of Pain in Older Adults.
    Romano RR; Anderson AR; Failla MD; Dietrich MS; Atalla S; Carter MA; Monroe TB
    J Alzheimers Dis; 2019; 70(3):715-722. PubMed ID: 31256133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Could Altered Evoked Pain Responsiveness Be a Phenotypic Biomarker for Alzheimer's Disease Risk? A Cross-Sectional Analysis of Cognitively Healthy Individuals.
    Romano RR; Carter MA; Dietrich MS; Cowan RL; Bruehl SP; Monroe TB
    J Alzheimers Dis; 2021; 79(3):1227-1233. PubMed ID: 33337380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Cross-Sectional Study of Pain Sensitivity and Unpleasantness in People with Vascular Dementia.
    Beach PA; Humbel A; Dietrich MS; Bruehl S; Cowan RL; Moss KO; Monroe TB
    Pain Med; 2022 Jul; 23(7):1231-1238. PubMed ID: 34791388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contact Heat Evoked Potentials (CHEPs) in Patients with Mild-Moderate Alzheimer's Disease and Matched Control--A Pilot Study.
    Jensen-Dahm C; Madsen CS; Waldemar G; Ballegaard M; Hejl AM; Johnsen B; Jensen TS
    Pain Med; 2016 Apr; 17(4):675-84. PubMed ID: 26814248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased pain unpleasantness and pain-related fMRI activation in the periaqueductal gray in Alzheimer's disease.
    Anderson AR; Monroe TB; Dietrich MS; Bruehl SP; Iversen WL; Cowan RL; Failla MD
    Front Pain Res (Lausanne); 2022; 3():914473. PubMed ID: 36387417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pain in Patients with Different Dementia Subtypes, Mild Cognitive Impairment, and Subjective Cognitive Impairment.
    Binnekade TT; Scherder EJA; Maier AB; Lobbezoo F; Overdorp EJ; Rhebergen D; Perez RSGM; Oosterman JM
    Pain Med; 2018 May; 19(5):920-927. PubMed ID: 29016892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer's disease.
    Siafarikas N; Selbaek G; Fladby T; Šaltytė Benth J; Auning E; Aarsland D
    Int Psychogeriatr; 2018 Jan; 30(1):103-113. PubMed ID: 28927477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative sensory testing and pain tolerance in patients with mild to moderate Alzheimer disease compared to healthy control subjects.
    Jensen-Dahm C; Werner MU; Dahl JB; Jensen TS; Ballegaard M; Hejl AM; Waldemar G
    Pain; 2014 Aug; 155(8):1439-1445. PubMed ID: 24412285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of unpleasant and pain thresholds of thermal stimuli in the orofacial regions: a psychophysical study using quantitative sensory testing in healthy young men.
    Kim HK; Kim ME
    Somatosens Mot Res; 2018 Jun; 35(2):139-147. PubMed ID: 30107761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An examination of pain perception and cerebral event-related potentials following carbon dioxide laser stimulation in patients with Alzheimer's disease and age-matched control volunteers.
    Gibson SJ; Voukelatos X; Ames D; Flicker L; Helme RD
    Pain Res Manag; 2001; 6(3):126-32. PubMed ID: 11854775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex differences in psychophysical and neurophysiological responses to pain in older adults: a cross-sectional study.
    Monroe TB; Gore JC; Bruehl SP; Benningfield MM; Dietrich MS; Chen LM; Newhouse P; Fillingim R; Chodkowski B; Atalla S; Arrieta J; Damon SM; Blackford JU; Cowan RL
    Biol Sex Differ; 2015; 6():25. PubMed ID: 26579217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimentally evoked pain in Alzheimer's disease.
    Anderson AR; Iversen WL; Carter MA; Moss KO; Cowan RL; Monroe TB
    J Am Assoc Nurse Pract; 2021 Mar; 34(1):18-25. PubMed ID: 33731557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motivational processes in mild cognitive impairment and Alzheimer's disease: results from the Motivational Reserve in Alzheimer's (MoReA) study.
    Forstmeier S; Maercker A
    BMC Psychiatry; 2015 Nov; 15():293. PubMed ID: 26578083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of odor identification among amnestic and non-amnestic mild cognitive impairment, subjective cognitive decline, and early Alzheimer's dementia.
    Park SJ; Lee JE; Lee KS; Kim JS
    Neurol Sci; 2018 Mar; 39(3):557-564. PubMed ID: 29383614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial.
    Wilcock GK; Black SE; Hendrix SB; Zavitz KH; Swabb EA; Laughlin MA;
    Lancet Neurol; 2008 Jun; 7(6):483-93. PubMed ID: 18450517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gait phenotype from mild cognitive impairment to moderate dementia: results from the GOOD initiative.
    Allali G; Annweiler C; Blumen HM; Callisaya ML; De Cock AM; Kressig RW; Srikanth V; Steinmetz JP; Verghese J; Beauchet O
    Eur J Neurol; 2016 Mar; 23(3):527-41. PubMed ID: 26662508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrepancy between stimulus response and tolerance of pain in Alzheimer disease.
    Jensen-Dahm C; Werner MU; Jensen TS; Ballegaard M; Andersen BB; Høgh P; Waldemar G
    Neurology; 2015 Apr; 84(15):1575-81. PubMed ID: 25788560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.